Reducing the price of treatment for multidrug-resistant tuberculosis through the Global Drug Facility

PROBLEM: Many countries have limited experience of securing the best prices for drugs and have little negotiating power. This is particularly true for the complex, lengthy and expensive regimens used to treat multidrug-resistant tuberculosis. APPROACH: The Stop TB Partnership’s Global Drug Facility...

Descripción completa

Detalles Bibliográficos
Autores principales: Lunte, Kaspars, Cordier-Lassalle, Thierry, Keravec, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization 2015
Materias:
Lessons from the Field
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431560/
https://www.ncbi.nlm.nih.gov/pubmed/26229192
http://dx.doi.org/10.2471/BLT.14.145920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431560/
https://www.ncbi.nlm.nih.gov/pubmed/26229192
http://dx.doi.org/10.2471/BLT.14.145920

Ejemplares similares